RHJA
VCYT icon

Rice Hall James & Associates’s Veracyte VCYT Stock Holding History

Rice Hall James & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Sell
95,586
-11,079
-10% -$465K 0.27% 91
2026
Q1 		$3.44M Sell
106,665
-1,477
-1% -$54.7K 0.19% 116
2025
Q4 		$4.55M Sell
108,142
-19,117
-15% -$771K 0.25% 89
2025
Q3 		$4.37M Sell
127,259
-1,034
-0.8% -$29.7K 0.24% 97
2025
Q2 		$3.47M Buy
128,293
+12,835
+11% +$372K 0.19% 124
2025
Q1 		$3.42M Buy
115,458
+19,843
+21% +$756K 0.2% 112
2024
Q4 		$3.79M Sell
95,615
-31,575
-25% -$1.2M 0.21% 112
2024
Q3 		$4.33M Buy
+127,190
New +$3.58M 0.23% 97

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Rice Hall James & Associates's VCYT Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Veracyte (VCYT) stake by 10% in Q2 2026, selling an estimated $465K and leaving 95,586 shares worth $5.61M. The position accounts for 0.27% of the portfolio, ranked #91.

Rice Hall James & Associates first reported a position in VCYT in Q3 2024 and has held it in 8 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Rice Hall James & Associates held 95,586 shares of Veracyte worth $5.61M as of Q2 2026.
  • Rice Hall James & Associates sold 11,079 Veracyte shares in Q2 2026, an estimated $465K.
  • Veracyte made up 0.27% of Rice Hall James & Associates's portfolio in Q2 2026, its #91 holding.
  • Rice Hall James & Associates first reported a position in Veracyte in Q3 2024 and has held it in 8 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.